DGAP-News: SHS Gesellschaft für Beteiligungsmanagement / Key word(s): Investment/Private Equity
2016-11-14 / 11:16
The issuer is solely responsible for the content of this announcement.
--------------------
*Tübingen/Balingen, November 14^th, 2016 - SHS Gesellschaft für Beteiligungsmanagement mbH has acquired medigroba GmbH. The transaction was achieved together with two experienced industry experts who will be the future management team. medigroba is a home care company situated in Balingen, Germany. The health care investor from Tübingen is planning to develop the company into one of the leading German suppliers of medical aid and care products. This will include promoting the company's organic growth and making targeted acquisitions.* *SHS is financing this transaction from its fourth fund.*
medigroba supplies patients in hospitals, nursing facilities and at home with medical aid and care products. It focuses on high-quality services as well as supplying medical technology products for home respiration, wound and stoma treatment, liquid, probe and intravenous nutrition, pain therapy and children's intensive care. The company provides in-house training and further qualification to its employees as well as external specialists. It currently has one main location in Balingen and employs 70 people. A total of over 3000 patients are serviced by medigroba. The company has a high single-digit million euro turnover."For many years now, medigroba has stood for patient-friendly and high-quality service. The company is well positioned in a dynamically growing market. We intend to promote continued growth in the next few years, which will include the acquisition of other home care providers in Germany", says Uwe Steinbacher, Managing Partner at SHS."We are very pleased to have the experienced healthcare investor SHS as medigroba's new majority shareholder. SHS will support the company's further growth, ensure stability and continuity and therefore also provide our customers and employees with an excellent perspective", explains Frank Franzen, Managing Director of medigroba GmbH."We look forward to the tasks that lie ahead. Together with our motivated employees, we plan to establish medigroba as a reliable partner for hospitals, nursing homes and health insurance companies beyond the borders of the State of Baden-Württemberg", says Bodo Weinitschke, who is also Managing Director of medigroba GmbH.The previous Managing Partner, Stefan Allgayer, will be actively accompanying the transition in the months to come.With the acquisition of medigroba, SHS is continuing to focus investments from its current fund with a volume of 125 million euro on expansion financing, changes in shareholder structures and succession situations. The Tübingen based investor is planning further acquisitions and investments in the fast-growing medical technology and healthcare industries in the months ahead. Since launching the fund in 2014, SHS has already invested in 11 companies.
*About SHS Gesellschaft für Beteiligungsmanagement mbH*
SHS Gesellschaft für Beteiligungsmanagement is based in Tübingen, Germany and invests in medical technology and life science companies with a focus on expansion financing, changes in shareholder structures and successor situations. SHS holds minority as well as majority interests. SHS was founded in 1993 and has since gained extensive experience as industry investor, which supports the growth of its portfolio companies through a network of partnerships regarding the introduction of new products, regulatory issues or entering new markets. The SHS fund's German and international investors include the European Investment Fund, professional pension insurers, retirement funds, funds of funds, family offices, entrepreneurs and the SHS management team. The AIFM-registered company is currently investing from its fourth generation of funds, for which investors have provided 125 million euro. Equity of up to 20 million euro is invested. Transactions can be carried out in the mid double-digit million range together with a network of co-investors. Reinhilde Spatscheck, Dr. Bernhard Schirmers, Hubertus Leonhardt and Uwe Steinbacher are the Managing Partners at SHS.
Further information: http://www.shs-capital.eu*About medigroba:*
The home care provider medigroba is situated in the German city of Balingen in Baden- Württemberg and is specialized in the care of patients in hospitals, nursing facilities and at home. Distinguishing characteristics include its 24-hour availability, its proximity to the patients and its highly qualified patient services. Speed, capacity and reliability round off medigroba's profile. The company is certified in accordance with DIN EN ISO 13485.
Further information: http://www.medigroba.de*Further information:*
Dr. Reinhard Saller
Ira Wülfing Kommunikation GmbH
Tel.: +49 (0) 89 2000 3038
Fax: +49 (0) 89 2000 3040
reinhard.saller@wuelfing-kommunikation.de
--------------------
2016-11-14 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de -------------------- Reported by EQS Group 2 hours ago.
2016-11-14 / 11:16
The issuer is solely responsible for the content of this announcement.
--------------------
*Tübingen/Balingen, November 14^th, 2016 - SHS Gesellschaft für Beteiligungsmanagement mbH has acquired medigroba GmbH. The transaction was achieved together with two experienced industry experts who will be the future management team. medigroba is a home care company situated in Balingen, Germany. The health care investor from Tübingen is planning to develop the company into one of the leading German suppliers of medical aid and care products. This will include promoting the company's organic growth and making targeted acquisitions.* *SHS is financing this transaction from its fourth fund.*
medigroba supplies patients in hospitals, nursing facilities and at home with medical aid and care products. It focuses on high-quality services as well as supplying medical technology products for home respiration, wound and stoma treatment, liquid, probe and intravenous nutrition, pain therapy and children's intensive care. The company provides in-house training and further qualification to its employees as well as external specialists. It currently has one main location in Balingen and employs 70 people. A total of over 3000 patients are serviced by medigroba. The company has a high single-digit million euro turnover."For many years now, medigroba has stood for patient-friendly and high-quality service. The company is well positioned in a dynamically growing market. We intend to promote continued growth in the next few years, which will include the acquisition of other home care providers in Germany", says Uwe Steinbacher, Managing Partner at SHS."We are very pleased to have the experienced healthcare investor SHS as medigroba's new majority shareholder. SHS will support the company's further growth, ensure stability and continuity and therefore also provide our customers and employees with an excellent perspective", explains Frank Franzen, Managing Director of medigroba GmbH."We look forward to the tasks that lie ahead. Together with our motivated employees, we plan to establish medigroba as a reliable partner for hospitals, nursing homes and health insurance companies beyond the borders of the State of Baden-Württemberg", says Bodo Weinitschke, who is also Managing Director of medigroba GmbH.The previous Managing Partner, Stefan Allgayer, will be actively accompanying the transition in the months to come.With the acquisition of medigroba, SHS is continuing to focus investments from its current fund with a volume of 125 million euro on expansion financing, changes in shareholder structures and succession situations. The Tübingen based investor is planning further acquisitions and investments in the fast-growing medical technology and healthcare industries in the months ahead. Since launching the fund in 2014, SHS has already invested in 11 companies.
*About SHS Gesellschaft für Beteiligungsmanagement mbH*
SHS Gesellschaft für Beteiligungsmanagement is based in Tübingen, Germany and invests in medical technology and life science companies with a focus on expansion financing, changes in shareholder structures and successor situations. SHS holds minority as well as majority interests. SHS was founded in 1993 and has since gained extensive experience as industry investor, which supports the growth of its portfolio companies through a network of partnerships regarding the introduction of new products, regulatory issues or entering new markets. The SHS fund's German and international investors include the European Investment Fund, professional pension insurers, retirement funds, funds of funds, family offices, entrepreneurs and the SHS management team. The AIFM-registered company is currently investing from its fourth generation of funds, for which investors have provided 125 million euro. Equity of up to 20 million euro is invested. Transactions can be carried out in the mid double-digit million range together with a network of co-investors. Reinhilde Spatscheck, Dr. Bernhard Schirmers, Hubertus Leonhardt and Uwe Steinbacher are the Managing Partners at SHS.
Further information: http://www.shs-capital.eu*About medigroba:*
The home care provider medigroba is situated in the German city of Balingen in Baden- Württemberg and is specialized in the care of patients in hospitals, nursing facilities and at home. Distinguishing characteristics include its 24-hour availability, its proximity to the patients and its highly qualified patient services. Speed, capacity and reliability round off medigroba's profile. The company is certified in accordance with DIN EN ISO 13485.
Further information: http://www.medigroba.de*Further information:*
Dr. Reinhard Saller
Ira Wülfing Kommunikation GmbH
Tel.: +49 (0) 89 2000 3038
Fax: +49 (0) 89 2000 3040
reinhard.saller@wuelfing-kommunikation.de
--------------------
2016-11-14 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de -------------------- Reported by EQS Group 2 hours ago.